Birbirini taklit eden iki hastalık: Behçet hastalığı ve sarkoidoz

Year 2022, Volume: 47 Issue: 4, 1761 - 1763, 28.12.2022

Bekir Torun , Burak Okyar , Esen Saba Oktem , Fatih Yıldız , Gözde Yıldırım Çetin

https://doi.org/10.17826/cumj.1169017

Abstract

Behçet hastalığı olarak bilinen Behçet Sendromu, tekrarlayan oral aftlar ile beraber genital aft, oküler hastalık,gastrointestinal tutulum, nörolojik tutulum, vasküler hastalık veya artrit gibi sistemik belirtilerden herhangi biri ile karakterizedir. Sarkoidoz dünyada genelinde görülen tuttuğu organlarda non -kazeife granülomlar ile karakterize olan etyoloji net olarak bilinmeyen granülomatöz bir hastalıktır. BS ve sarkoidozun klinik seyrinde üveit, poliartrit, menenjit, kardiyovasküler hastalık, göğüs radyografilerinde anormallik izlendiğinden her iki hastalık birbirleri ile karıştırılabilir.

Keywords

behçet sendromu, sarkoidoz, üveit

Supporting Institution

YOK

Project Number

YOK

Two diseases that mimic each other: Behçet disease and sarcoidosis

Abstract

Behçet syndrome(BS), also known as Behçet disease (BD), is characterized by recurrent oral aphthae and any of several systemic manifestations including genital aphthae, ocular disease, skin lesions, gastrointestinal involvement, neurologic disease, vascular disease or arthritis. Sarcoidosis is a multisystem granulomatous disorder of unknown etiology that affects individuals worldwide and is characterized pathologically by the presence of noncaseating granulomas in involved organs. BD may be confused with sarcoidosis because they are both multisystem inflammatory disorders presenting with uveitis, polyarthritis, meningitis, cardiovascular disease, erythema nodosum, and other cutaneous lesions, and abnormal chest radiographs.

Keywords

behçet syndrome, sarcoidosis, uveitis

Project Number

YOK

References

• Referans1 GulenHatemi, Peter A. Merkel, Vedat Hamuryudan, MaartenBoers, Haner Direskeneli, Sibel Z. Aydin, Hasan Yazici. OutcomeMeasuresUsed in ClinicalTrialsfor Behçet Syndrome: A SystematicReview J Rheumatol. Author manuscript; available in PMC 2015 Jul 20. 2014 Mar; 41(3): 599–612.
• Referans2 Sandro F. Perazzio, Luis E. C. Andrade, Alexandre W. S. de Souza. Understanding Behçet’s Disease in the Context of Innate Immunity Activation Front Immunol. 2020; 11: 586558.
• Referans3 Pleiades T. Inaoka, Masato Shono, Mishio Kamada, J. Luis Espinoza. Host-microbe interactions in the pathogenesis and clinical course of sarcoidosis J Biomed Sci. 2019; 26: 45.
• Referans4 Thomas W. McNally, Erika M. Damato, Philip I. Murray, Alastair K. Denniston, Robert J. BarryOrphanet J. An update on the use of biologic therapies in the management of uveitis in Behçet’s disease: a comprehensive review Rare Dis. 2017; 12: 130.
• Referans5 Julie Gueudry, Mathilde Leclercq, David Saadoun, Bahram Bodaghi. Old and New Challenges in Uveitis Associated with Behçet’s Disease J Clin Med. 2021 Jun; 10(11): 2318.
• Referans6 Sarcoidosis Robicheaux Clementine, Rochelle MD*; Lyman, Justin MD*; Zakem, Jerald MD*; Mallepalli, Jyothi MD†; Lindsey, Stephen MD*; Quinet, Robert MD* . Tumor Necrosis Factor-Alpha Antagonist-Induced JCR: Journal of Clinical Rheumatology: September 2010 - Volume 16 - Issue 6 - p 274-279.